PL125636B1 - Process for preparing substituted 6-aryl-4h-s-triazol/3,4-c/-thien-/2,3-e/-1,4-diazepines - Google Patents
Process for preparing substituted 6-aryl-4h-s-triazol/3,4-c/-thien-/2,3-e/-1,4-diazepines Download PDFInfo
- Publication number
- PL125636B1 PL125636B1 PL1980227128A PL22712880A PL125636B1 PL 125636 B1 PL125636 B1 PL 125636B1 PL 1980227128 A PL1980227128 A PL 1980227128A PL 22712880 A PL22712880 A PL 22712880A PL 125636 B1 PL125636 B1 PL 125636B1
- Authority
- PL
- Poland
- Prior art keywords
- model
- group
- general formula
- carbon atoms
- formula
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 3
- 238000000034 method Methods 0.000 claims description 16
- 239000000460 chlorine Chemical group 0.000 claims description 15
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- -1 hydroxyl compound Chemical class 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 230000002152 alkylating effect Effects 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- DVAZKUDTZUIOQK-UHFFFAOYSA-M 2-bromo-1-methylpyridin-1-ium;iodide Chemical compound [I-].C[N+]1=CC=CC=C1Br DVAZKUDTZUIOQK-UHFFFAOYSA-M 0.000 claims description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 claims description 2
- XRKQMIFKHDXFNQ-UHFFFAOYSA-N n-cyclohexyl-n-ethylcyclohexanamine Chemical compound C1CCCCC1N(CC)C1CCCCC1 XRKQMIFKHDXFNQ-UHFFFAOYSA-N 0.000 claims description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 150000004911 1,4-diazepines Chemical class 0.000 claims 1
- VDVUCLWJZJHFAV-UHFFFAOYSA-N 2,2,6,6-tetramethylpiperidin-4-ol Chemical compound CC1(C)CC(O)CC(C)(C)N1 VDVUCLWJZJHFAV-UHFFFAOYSA-N 0.000 claims 1
- ABFPKTQEQNICFT-UHFFFAOYSA-M 2-chloro-1-methylpyridin-1-ium;iodide Chemical compound [I-].C[N+]1=CC=CC=C1Cl ABFPKTQEQNICFT-UHFFFAOYSA-M 0.000 claims 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Chemical group 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000012467 final product Substances 0.000 claims 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 9
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 7
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- VXHWVRJTNQQBHM-UHFFFAOYSA-N 2,2,6,6-tetraethylpiperidin-4-ol Chemical compound CCC1(CC)CC(O)CC(CC)(CC)N1 VXHWVRJTNQQBHM-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- JWLAZGQOSYCIPW-UHFFFAOYSA-N ON(CC(C=C1)=C(N(C2)C3=NN2Br)[S+]1Br)C3C(C=CC=C1)=C1Cl Chemical class ON(CC(C=C1)=C(N(C2)C3=NN2Br)[S+]1Br)C3C(C=CC=C1)=C1Cl JWLAZGQOSYCIPW-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940013688 formic acid Drugs 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- SFJGCXYXEFWEBK-UHFFFAOYSA-N oxazepine Chemical group O1C=CC=CC=N1 SFJGCXYXEFWEBK-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/71—Ceramic products containing macroscopic reinforcing agents
- C04B35/78—Ceramic products containing macroscopic reinforcing agents containing non-metallic materials
- C04B35/80—Fibres, filaments, whiskers, platelets, or the like
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Ceramic Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Manufacturing & Machinery (AREA)
- Materials Engineering (AREA)
- Structural Engineering (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19792940737 DE2940737A1 (de) | 1979-10-08 | 1979-10-08 | Verfahren zur herstellung von substituierten 6-aryl- 4h-s-triazolo-(3,4-c)-thieno-(2,3-e)-1,4-diazepinen |
Publications (2)
Publication Number | Publication Date |
---|---|
PL227128A1 PL227128A1 (enrdf_load_stackoverflow) | 1981-06-05 |
PL125636B1 true PL125636B1 (en) | 1983-06-30 |
Family
ID=6082971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1980227128A PL125636B1 (en) | 1979-10-08 | 1980-10-06 | Process for preparing substituted 6-aryl-4h-s-triazol/3,4-c/-thien-/2,3-e/-1,4-diazepines |
Country Status (18)
-
1979
- 1979-10-08 DE DE19792940737 patent/DE2940737A1/de active Granted
-
1980
- 1980-09-24 AT AT0475780A patent/AT371820B/de not_active IP Right Cessation
- 1980-10-03 GR GR63045A patent/GR70773B/el unknown
- 1980-10-03 SU SU802992903A patent/SU1056904A3/ru active
- 1980-10-06 LU LU82825A patent/LU82825A1/de unknown
- 1980-10-06 HU HU802432A patent/HU181744B/hu not_active IP Right Cessation
- 1980-10-06 CH CH745180A patent/CH645114A5/de not_active IP Right Cessation
- 1980-10-06 FI FI803161A patent/FI68837C/fi not_active IP Right Cessation
- 1980-10-06 CS CS806739A patent/CS215141B2/cs unknown
- 1980-10-06 PL PL1980227128A patent/PL125636B1/pl unknown
- 1980-10-06 DD DD80224375A patent/DD153373A5/de unknown
- 1980-10-07 YU YU02571/80A patent/YU257180A/xx unknown
- 1980-10-07 PT PT71884A patent/PT71884B/pt not_active IP Right Cessation
- 1980-10-07 DK DK423280A patent/DK154505C/da not_active IP Right Cessation
- 1980-10-07 SE SE8007021A patent/SE441927B/sv not_active IP Right Cessation
- 1980-10-07 NO NO802987A patent/NO156652C/no unknown
- 1980-10-07 ES ES495689A patent/ES495689A0/es active Granted
- 1980-10-07 JP JP13942480A patent/JPS5661383A/ja active Granted
-
1981
- 1981-07-01 ES ES503584A patent/ES503584A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
ATA475780A (de) | 1982-12-15 |
AT371820B (de) | 1983-08-10 |
JPS5661383A (en) | 1981-05-26 |
NO156652C (no) | 1987-10-28 |
ES8205807A1 (es) | 1982-06-16 |
HU181744B (en) | 1983-11-28 |
SE8007021L (sv) | 1981-04-09 |
DK154505C (da) | 1989-04-17 |
PL227128A1 (enrdf_load_stackoverflow) | 1981-06-05 |
ES8200892A1 (es) | 1981-11-16 |
SE441927B (sv) | 1985-11-18 |
YU257180A (en) | 1983-02-28 |
ES503584A0 (es) | 1982-06-16 |
NO156652B (no) | 1987-07-20 |
DE2940737A1 (de) | 1981-04-16 |
PT71884B (de) | 1982-06-15 |
CH645114A5 (en) | 1984-09-14 |
DD153373A5 (de) | 1982-01-06 |
FI68837B (fi) | 1985-07-31 |
JPH0219118B2 (enrdf_load_stackoverflow) | 1990-04-27 |
SU1056904A3 (ru) | 1983-11-23 |
LU82825A1 (de) | 1981-12-02 |
DK423280A (da) | 1981-04-09 |
DE2940737C2 (enrdf_load_stackoverflow) | 1988-12-15 |
FI803161L (fi) | 1981-04-09 |
FI68837C (fi) | 1985-11-11 |
CS215141B2 (en) | 1982-07-30 |
NO802987L (no) | 1981-04-09 |
GR70773B (enrdf_load_stackoverflow) | 1983-03-22 |
DK154505B (da) | 1988-11-21 |
ES495689A0 (es) | 1981-11-16 |
PT71884A (de) | 1980-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3534019A (en) | Dibenzoxazepine - n - carboxylic acid hydrazides and related compounds | |
FI59099B (fi) | Foerfarande foer framstaellning av terapeutiskt vaerdefulla substituerade 6-fenyl-4h-s-triazolo-/3,4c/-tieno-/2,3e/-1,4-diazepiner | |
El‐Dawy et al. | Potential broad spectrum anthelmintics IV: Design, synthesis, and antiparasitic screening of certain 3, 6‐disubstituted‐(7H)‐s‐triazolo‐[3, 4‐b][1, 3, 4] thiadiazine derivatives | |
NO151348B (no) | Trikot stroempebukse og fremgangsmaate for fremstilling av samme | |
US3703525A (en) | Triazolo(1,5-a)(1,4)benzodiazepine derivatives | |
PL125636B1 (en) | Process for preparing substituted 6-aryl-4h-s-triazol/3,4-c/-thien-/2,3-e/-1,4-diazepines | |
PL97304B1 (pl) | Sposob wytwarzania nowych pochodnych tienotriazolodwuazepiny | |
US3714148A (en) | Process for preparing dibenzazocine derivatives and salts thereof | |
US3920687A (en) | 2,3,6,7-tetrahydro-6-phenyl-5h-imidazo(1,2-d)+8 1,4)benzodiazepin-5-ones and diazepines | |
NO140860B (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive triazolo-1,5-benzodiazepiner | |
US3446806A (en) | Process for the preparation of 1,4-benzodiazepine 4-oxides | |
US3828039A (en) | 2-amino-thieno(2,3-e)(1,4)diazepine compounds | |
HU215916B (hu) | Helyettesített N-amino-alkil-metán-szulfanilid görcsoldók, ezeket tartalmazó gyógyszerkészítmények, és eljárás előállításukra | |
US3215694A (en) | Quinazoline-z-carboxaldehydes, acids, intermediates and process | |
US3887541A (en) | 1,4-Benzodiazepine derivatives | |
US3629262A (en) | Process for preparing 4-phenyl-quinazolines | |
FI78290B (fi) | 3-(pyridyloxi)pyrrolidin- och 3-(pyridyloxi)-azedinderivat, som aer anvaendbara som mellanprodukter. | |
PL150760B1 (en) | Method of obtaining aromatic 1,4-oxazepinones and thiones | |
Potts et al. | Nonclassical heteropentalenes containing the selenodiazole, thiatriazole and selenotriazole ring systems | |
US3644417A (en) | Coronary vasodilator compounds | |
FI63032C (fi) | Foerfarande foer framstaellning av substituerade 6-fenyl-4h-s-triazolo-(3,4-c)-tieno-(2,3-e)-1,4-diazepiner | |
PL82688B1 (en) | Benzodiazepine derivatives preparation[gb1276909a] | |
US3746701A (en) | Method for the production of benzodiazepine derivatives | |
HU203099B (en) | Process for producing condensed quinolinium- and isoquinolinium derivatives and pharmaceutical compositions containing them | |
Gómez‐Parra et al. | Potential H1‐Antihistaminic Drugs: Synthesis of 4‐[(2, 3‐Dihydro‐2‐oxo‐1H‐benzimidazol‐1‐yl) alkoxycarbonyl]‐1‐(diphenylmethyl) piperazines by Selective Monoalkoxycarbonylation of α, ω‐Dichloroalkanes by Phase‐Transfer Catalysis |